Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion type Assertion NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_head.
- NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion description "[The objective of this study was to investigate the therapeutic potential of ���I added to doxorubicin therapy in multidrug resistance (MDR) mouse colon cancer coexpressing the MDR1 small hairpin RNA (shRNA) and human sodium iodide symporter (hNIS) gene in a single gene construct and to visualize the antitumor effects using molecular nuclear imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_provenance.
- NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion evidence source_evidence_literature NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_provenance.
- NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion SIO_000772 21204761 NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_provenance.
- NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion wasDerivedFrom befree-20140225 NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_provenance.
- NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_assertion wasGeneratedBy ECO_0000203 NP163313.RAmBMCeRV_Tud9X-4lZszt2bhsuZzieDcC4IVIcuJCwcU130_provenance.